| Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia (NCT00641745) | Sumitomo Pharma America, Inc. | 2008-03-01 |
| Efficacy of Bifeprunox in Patients With Schizophrenia (NCT00658645) | H. Lundbeck A/S | 2008-03-01 |
| A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia. (NCT00616798) | Hoffmann-La Roche | 2008-03-01 |
| Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment (NCT00692133) | AstraZeneca | 2008-03-01 |
| Oxytocin Add on Study for Stable Schizophrenic Patients (NCT00506909) | David Feifel | 2008-03-01 |
| A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia (NCT00642369) | Guang Dong Provincial Mental Health Institute | 2008-03-01 |
| An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia (NCT00757705) | Johnson & Johnson Taiwan Ltd | 2008-03-01 |
| A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia (NCT00640510) | Eli Lilly and Company | 2008-03-01 |
| Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients (NCT00554658) | University of Regensburg | 2008-03-01 |
| Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia (NCT00640601) | AstraZeneca | 2008-03-01 |
| Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia (NCT00654706) | H. Lundbeck A/S | 2008-03-01 |
| Study of CYR-101 in Patients With Schizophrenia (NCT00861796) | Cyrenaic Pharmaceuticals | 2008-03-01 |
| A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia (NCT01559272) | Janssen Research & Development, LLC | 2008-02-21 |
| A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone (NCT01010776) | Janssen-Cilag Farmaceutica Ltda. | 2008-02-01 |
| Quetiapine Extended Release Depression Symptoms (NCT00640562) | AstraZeneca | 2008-02-01 |
| Add-on Simvastatin in Schizophrenia Trial (NCT00605995) | New York State Psychiatric Institute | 2008-02-01 |
| The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients (NCT00629252) | University of Zurich | 2008-02-01 |
| Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment (NCT00707382) | Gesche Jurgens | 2008-02-01 |
| Cerebellar rTMS for the Treatment of Schizophrenic Patients (NCT01072617) | Beth Israel Deaconess Medical Center | 2008-02-01 |
| Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia (NCT01724359) | Janssen-Cilag, S.A. | 2008-02-01 |
| Improving Insight in Patients Diagnosed With Schizophrenia (NCT01282307) | University of Aarhus | 2008-02-01 |
| Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder (NCT00838227) | Manhattan Psychiatric Center | 2008-02-01 |
| Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia (NCT00783120) | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | 2008-01-01 |
| Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia (NCT00585390) | University of Cincinnati | 2008-01-01 |
| Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics (NCT03730857) | Calo Psychiatric Center | 2008-01-01 |
| Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine (NCT01401491) | Taipei Medical University Hospital | 2008-01-01 |
| Illness Management and Recovery for Veterans With Severe Mental Illness (NCT00515671) | VA Office of Research and Development | 2008-01-01 |
| Effects of Cognitive Remediation Therapy on Schizophrenia Patients Through Functional Magnetic Resonance Imaging (NCT01318850) | Hospital Clinic of Barcelona | 2008-01-01 |
| Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant Schizophrenia (NCT00565175) | Jesper Ekelund | 2008-01-01 |
| Family-based Genetic Long-term Study of Brain Function in Schizophrenia (NCT01045824) | Taichung Veterans General Hospital | 2008-01-01 |
| Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia (NCT00615433) | Sumitomo Pharma America, Inc. | 2008-01-01 |
| A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia (NCT01615185) | Kaohsiung Kai-Suan Psychiatric Hospital | 2008-01-01 |
| Efficacy of Social Cognition Training in Schizophrenia (NCT00587561) | VA Connecticut Healthcare System | 2008-01-01 |
| Antipsychotic Polypharmacy: Prevalence, Background and Consequences (NCT00541398) | Glostrup University Hospital, Copenhagen | 2008-01-01 |
| Schizophrenic Patients Taking Part in Integrated Care Program (NCT00617214) | AstraZeneca | 2008-01-01 |
| A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia (NCT00604279) | Xian-Janssen Pharmaceutical Ltd. | 2008-01-01 |
| Training-induced Cerebral Reorganization in Schizophrenia (NCT00695708) | University of Konstanz | 2008-01-01 |
| Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail (NCT00618280) | Heinrich-Heine University, Duesseldorf | 2008-01-01 |
| Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia (NCT00611806) | Massachusetts General Hospital | 2007-12-01 |
| Intranasal Insulin Treatment in Patients With Schizophrenia (NCT00575666) | University of Massachusetts, Worcester | 2007-12-01 |
| Knowledge and Perception of Smoking Risks/Consequences (NCT00686101) | University of Maryland, Baltimore | 2007-12-01 |
| A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia (NCT01606228) | Janssen Pharmaceutica | 2007-12-01 |
| Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics (NCT00569504) | Seoul National Hospital | 2007-12-01 |
| Study Evaluating Vabicaserin in Subjects With Schizophrenia (NCT00563706) | Pfizer | 2007-12-01 |
| Conversion to Antipsychotic Monotherapy (NCT01368458) | Nathan Kline Institute for Psychiatric Research | 2007-12-01 |
| A Comparison of Two Cognitive Batteries in People With Schizophrenia (NCT00499044) | North Suffolk Mental Health Association | 2007-12-01 |
| Neurophysiological Studies in Schizophrenia and Psychiatric Disorders (NCT01384604) | University of Texas Southwestern Medical Center | 2007-12-01 |
| An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder (NCT00992407) | Janssen Korea, Ltd., Korea | 2007-12-01 |
| Effect on Metabolic Parameters of Abilify in SPR (NCT00569764) | Seoul National Hospital | 2007-12-01 |
| Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism (NCT02675530) | Yale University | 2007-12-01 |
| Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia (NCT00575848) | North Suffolk Mental Health Association | 2007-12-01 |
| Mindfulness Meditation as a Rehabilitation Strategy for Persons With Schizophrenia (NCT00936351) | US Department of Veterans Affairs | 2007-12-01 |
| The Effects of Rimonabant, on Weight and Metabolic Risk Factors (NCT00547118) | University of Maryland, Baltimore | 2007-11-01 |
| Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia (NCT00509067) | Georgetown University | 2007-11-01 |
| Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo (NCT00570063) | Pfizer | 2007-11-01 |
| Bone Density in Patients With Schizophrenia (NCT00540267) | Inje University | 2007-11-01 |
| Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia (NCT00763438) | H. Lundbeck A/S | 2007-11-01 |
| An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders (NCT01855074) | Janssen-Cilag Ltd. | 2007-11-01 |
| Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia (NCT00690235) | University of Texas Southwestern Medical Center | 2007-11-01 |
| A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia (NCT00567203) | Pfizer | 2007-11-01 |
| Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia (NCT00554840) | University of Maryland, Baltimore | 2007-11-01 |
| Effects of Motivating People With Schizophrenia to Exercise (NCT00559572) | The University of Tennessee, Knoxville | 2007-11-01 |
| An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics (NCT00448630) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-10-23 |
| Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox (NCT00538629) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-10-16 |
| A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis (NCT00591318) | Research Foundation for Mental Hygiene, Inc. | 2007-10-10 |
| Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia (NCT00549718) | Sumitomo Pharma America, Inc. | 2007-10-01 |
| Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study (NCT01479400) | Central South University | 2007-10-01 |
| Quality of Life in Schizophrenic Patients (NCT00597168) | AstraZeneca | 2007-10-01 |
| Digital Voice Analysis in Patients With Schizophrenia (NCT00524979) | BeerYaakov Mental Health Center | 2007-10-01 |
| Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone (NCT00535132) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-10-01 |
| Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia (NCT00717509) | Seoul National Hospital | 2007-10-01 |
| A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia (NCT00645099) | Janssen-Cilag International NV | 2007-10-01 |
| Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Original Study (NCT00567281) | Yale University | 2007-10-01 |
| Early Detection and Intervention for the Prevention of Psychosis (NCT00531518) | MaineHealth | 2007-10-01 |
| The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype (NCT00548327) | National Institute of Mental Health (NIMH) | 2007-10-01 |
| Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease (NCT00535145) | Ortho-McNeil Janssen Scientific Affairs, LLC | 2007-10-01 |
| Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis (NCT00484302) | Bispebjerg Hospital | 2007-09-01 |
| The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness. (NCT00466323) | US Department of Veterans Affairs | 2007-09-01 |
| An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia (NCT00996242) | Göteborg University | 2007-09-01 |
| Evaluation of Dorsal Visual Stream in Patients With Schizophrenia (NCT01378403) | Sheba Medical Center | 2007-09-01 |
| A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition (NCT00525304) | University of Maryland, Baltimore | 2007-09-01 |
| Improving Basic and Social Cognition in Veterans With Schizophrenia (NCT00470106) | VA Office of Research and Development | 2007-09-01 |
| A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia (NCT01150448) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-09-01 |
| Antipsychotics and Blood Vessel Function (NCT00585273) | Jess G. Fiedorowicz | 2007-09-01 |
| The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia (NCT00523445) | Inje University | 2007-09-01 |
| A Study for Patients With Schizophrenia (NCT00520923) | Eli Lilly and Company | 2007-09-01 |
| An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia (NCT00524043) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-09-01 |
| First Time in Human Study With GSK1018921 (NCT00527020) | GlaxoSmithKline | 2007-08-10 |
| A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression (NCT00481026) | Bayside Health | 2007-08-01 |
| Complex Problem Solving Training in Schizophrenic Patients (NCT00507988) | Heidelberg University | 2007-08-01 |
| A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia (NCT00538070) | Massachusetts General Hospital | 2007-08-01 |
| Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia (NCT00694889) | University of California, San Francisco | 2007-08-01 |
| A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients (NCT00518323) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-08-01 |
| Study Comparing Bioavailability of Oral Formulations of Vabicaserin (NCT00541996) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia (NCT00528905) | AstraZeneca | 2007-08-01 |
| Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients (NCT01149577) | Central Institute of Psychiatry, Ranchi, India | 2007-08-01 |
| Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia (NCT01368406) | Federal University of São Paulo | 2007-08-01 |
| Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia (NCT00998608) | Kaohsiung Kai-Suan Psychiatric Hospital | 2007-08-01 |
| Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study (NCT00511277) | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | 2007-08-01 |
| Emotional and Cognitive Abilites of Schizophrenia Patients at Various Time Points (NCT00518999) | Shalvata Mental Health Center | 2007-08-01 |